Results 111 to 120 of about 72,749 (293)
Nano Select, EarlyView.Graphical abstract illustrates the semiconductor nanomaterials (SNMs) and their coatings on various surfaces to prevent microbial infection ABSTRACT Throughout the course of human civilization, numerous disease outbreaks have caused major impacts by affecting the lives of mankind.
Ravichandran Manisekaran +6 more
wiley +1 more source
A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
Biologics: Targets & Therapy, 2013 Johan Bennett, Christophe DuboisDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, BelgiumAbstract: The development of coronary stents represents a major step forward in the treatment of obstructive coronary artery disease since ...
Bennett J, Dubois C
doaj
Interventional oncology in children: Where are we now?
Journal of Medical Imaging and Radiation Oncology, EarlyView.Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel +1 more
wiley +1 more source
Research progress of drug eluting balloon in arterial circulatory system
Frontiers in Cardiovascular MedicineThe arterial circulatory system diseases are common in clinical practice, and their treatment options have been of great interest due to their high morbidity and mortality.
Keji Lu +13 more
doaj +1 more source
Reviews in Cardiovascular Medicine, 2010 Significant evolution in catheter-based technologies for percutaneous coronary intervention has occurred since the introduction of coronary balloon angioplasty by Andreas Grüntzig in 1977. As balloon angioplasty was supplanted by bare metal stents and subsequently drug-eluting stents (DES), randomized comparative clinical trials have demonstrated a ...
openaire +3 more sources
Medicare to partly cover extra cost of sepsis therapy, drug-eluting stents [PDF]
, 2002 Cheryl A. Thompson
openalex +1 more source
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
New England Journal of Medicine, 2007 BACKGROUND Recent reports have indicated that there may be an increased risk of late stent thrombosis with the use of drug-eluting stents, as compared with bare-metal stents.
B. Lagerqvist +5 more
semanticscholar +1 more source
Patient-Specific 3D Volumetric Reconstruction of Bioresorbable Stents: A Method to Generate 3D Geometries for Computational Analysis of Coronaries Treated with Bioresorbable Stents [PDF]
arXiv, 2018 As experts continue to debate the optimal surgery practice for coronary disease - percutaneous coronary intervention (PCI) or coronary aortic bypass graft (CABG) - computational tools may provide a quantitative assessment of each option. Computational fluid dynamics (CFD) has been used to assess the interplay between hemodynamics and stent struts; it ...
arxiv
Stent Thrombosis With Drug-Eluting Stents
Journal of the American College of Cardiology, 2013 First-generation drug-eluting stents (DES), which impart the controlled release of sirolimus or paclitaxel from durable polymers to the vessel wall, have been consistently shown to reduce the risk of restenosis and target vessel revascularization compared with bare metal stents (BMS).
T. Palmerini +6 more
openaire +3 more sources
Drug-Eluting Stents in Preclinical Studies [PDF]
, 2002 Robert S. Schwartz +11 more
openalex +1 more source